Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients

Conditions

Paediatric Liver Transplant Recipients

What is the purpose of this trial?

This study is designed to assess the evolution of renal function and to collect efficacy, safety, and tolerability data of everolimus in co-exposure with reduced CNI in paediatric liver transplant recipients.


Participation Guidelines

Age:
1 Months - 17 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Novartis Pharmaceuticals
Dates:
02/25/2014
Last Updated:
Study HIC#:
1309012697